PT-141 10mg is a research peptide vial of bremelanotide. Learn about dosing, nasal spray vs injection, duration, safety, and where to buy it.
PT-141 10mg refers to a 10-milligram vial of bremelanotide, a synthetic peptide sold for laboratory research. The FDA-approved version of bremelanotide is Vyleesi, a 1.75 mg subcutaneous autoinjector for premenopausal women with hypoactive sexual desire disorder (HSDD). A 10 mg vial is not an FDA-approved product and is not intended for human consumption.
What Is PT-141 10mg?
Bremelanotide is a melanocortin receptor agonist that acts on the central nervous system. It was originally studied as a tanning agent before researchers noticed effects on sexual desire. The 10 mg vial is typically a lyophilized powder that researchers reconstitute with bacteriostatic water.
This vial size is popular in research settings because it allows for multiple small aliquots. It is not the same as the prescription product Vyleesi, which contains 1.75 mg per autoinjector. A 10 mg vial is roughly 5.7 times the approved single dose.
PT-141 10mg Dosing and Research Context
In research discussions, pt-141 10mg dosage women often references the approved 1.75 mg subcutaneous dose. That dose is given as needed, at least 45 minutes before anticipated sexual activity, and no more than once in 24 hours.
For a 10 mg vial, a researcher might reconstitute with 1 mL of bacteriostatic water, yielding 10 mg/mL. A 1.75 mg dose would then be 0.175 mL. However, this is a mathematical example only—not a dosing recommendation for human use.
- Approved dose: 1.75 mg subcutaneous injection (Vyleesi).
- Maximum frequency: Once per 24 hours, no more than 8 doses per month.
- 10 mg vial: Contains about 5.7 approved doses if reconstituted accurately.
PT-141 is not approved for use in men, and no safe or effective dose has been established for male use. Any human use of a 10 mg research vial is off-label, unregulated, and potentially unsafe.
PT-141 Nasal Spray vs Injection
The pt-141 nasal spray vs injection comparison comes up often because early clinical trials used a nasal formulation. That formulation was discontinued due to variable absorption and dosing challenges. Today, the only FDA-approved form is an injection.
A compounded nasal spray is not an approved product. Some researchers ask how to make one by mixing reconstituted peptide with saline, but sterility, pH, and dosing accuracy are major concerns. Compounded nasal sprays are not standardized and may deliver inconsistent amounts.
| Feature | Subcutaneous Injection (Vyleesi) | Compounded Nasal Spray |
|---|---|---|
| FDA approval | Approved for HSDD in premenopausal women | Not FDA-approved |
| Typical dose | 1.75 mg | Variable; research often uses 10 mg or more |
| Onset | About 15–60 minutes | Reported 15–30 minutes in some studies |
| Duration | About 2–4 hours | Variable and less predictable |
| Bioavailability | High and consistent | Lower and inconsistent |
How Long Does PT-141 Last and Take to Work?
A common question is how long does pt-141 last; most reports suggest effects last 2 to 4 hours after injection. Another common question is how quickly it takes to work, with onset typically 15 to 60 minutes. The nasal spray may act slightly faster but with less reliability.
Factors that affect duration include dose, route of administration, individual metabolism, and whether the peptide was stored properly. Reconstituted peptide should be refrigerated and used within a few weeks, according to most supplier guidelines.
Safety, Legal Status, and Where to Buy PT-141
If you are searching where to buy pt-141, know that Vyleesi requires a prescription from a healthcare professional. Research vials, including a pt-141 bremelanotide injection 20mg vial, are sold online for laboratory use only. The FDA has not approved these vials for human use, and their purity and sterility are not guaranteed.
Reported side effects of bremelanotide include nausea, flushing, headache, injection site reactions, and darkening of the skin. It can also temporarily raise blood pressure. People with cardiovascular disease or uncontrolled hypertension should not use it.
PT-141 is not a cure for sexual dysfunction, and it is not approved for recreational use. Anyone considering it should consult a licensed healthcare provider.
Frequently Asked Questions
What is a PT-141 10mg vial used for?
A PT-141 10mg vial is sold for laboratory research, not for human consumption. The approved drug Vyleesi contains 1.75 mg of bremelanotide and is used for HSDD in premenopausal women. Researchers may use the 10 mg vial to study peptide stability, receptor activity, or analytical methods.
Can I use a PT-141 10mg vial for myself?
No. A 10 mg research vial is not sterile for injection and is not dosed for human use. Using it without medical supervision can cause serious side effects, including severe nausea, blood pressure changes, and skin darkening. Only a licensed prescriber can provide Vyleesi.
How should PT-141 10mg be stored?
Lyophilized powder should be stored in a freezer, protected from light and moisture. After reconstitution with bacteriostatic water, it should be refrigerated at 2–8°C and used within 2–4 weeks. Always follow the supplier’s certificate of analysis and storage instructions.
Frequently Asked Questions
What is a PT-141 10mg vial used for?
A PT-141 10mg vial is sold for laboratory research, not for human consumption. The approved drug Vyleesi contains 1.75 mg of bremelanotide and is used for HSDD in premenopausal women. Researchers may use the 10 mg vial to study peptide stability, receptor activity, or analytical methods.
Can I use a PT-141 10mg vial for myself?
No. A 10 mg research vial is not sterile for injection and is not dosed for human use. Using it without medical supervision can cause serious side effects, including severe nausea, blood pressure changes, and skin darkening. Only a licensed prescriber can provide Vyleesi.
How should PT-141 10mg be stored?
Lyophilized powder should be stored in a freezer, protected from light and moisture. After reconstitution with bacteriostatic water, it should be refrigerated at 2–8°C and used within 2–4 weeks. Always follow the supplier’s certificate of analysis and storage instructions.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.